What is it about?
Pulmonary Hypertension is a life-threatening cardiopulmonary disorder where inflammation and immunity have emerged as critical pathogenic elements. We tested whether activation of the Complement cascade is essential in regulating pro-inflammatory and pro-proliferative processes in initiation of experimental pulmonary hypertension. We establish, as we believe for the first time, immunoglobulin-driven dysregulated complement activation as a critical pathological mechanism regulating initiation of the disease process.
Featured Image
Read the Original
This page is a summary of: Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, January 2020, American Thoracic Society,
DOI: 10.1164/rccm.201903-0591oc.
You can read the full text:
Contributors
Be the first to contribute to this page







